Clinical trial
RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT…
NCT00495378 · Ortho Biotech Products, L.P., Industry · Terminated
Key facts
| NCT number | NCT00495378 |
|---|---|
| Title | RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia |
| Official title | Retrospective Review of Alternate PROCRIT Dosing In Patients With Chemotherapy Related Anemia |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chemotherapy, Cancer, Anemia |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 25 |
| Start date | Nov 1, 2002 |
| Completion | Mar 1, 2003 |
| First posted | Jul 3, 2007 |
| Last update posted | Dec 20, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: